Literature DB >> 25221671

P450-catalyzed asymmetric cyclopropanation of electron-deficient olefins under aerobic conditions.

Hans Renata1, Z Jane Wang1, Rebekah Z Kitto1, Frances H Arnold1.   

Abstract

A variant of P450 from Bacillus megaterium five mutations away from wild type is a highly active catalyst for cyclopropanation of a variety of acrylamide and acrylate olefins with ethyl diazoacetate (EDA). The very high rate of reaction enabled by histidine ligation allowed the reaction to be conducted under aerobic conditions. The promiscuity of this catalyst for a variety of substrates containing amides has enabled synthesis of a small library of precursors to levomilnacipran derivatives.

Entities:  

Year:  2014        PMID: 25221671      PMCID: PMC4159215          DOI: 10.1039/C4CY00633J

Source DB:  PubMed          Journal:  Catal Sci Technol        ISSN: 2044-4753            Impact factor:   6.119


  10 in total

1.  Stereoselective cyclopropanation reactions.

Authors:  Hélène Lebel; Jean-François Marcoux; Carmela Molinaro; André B Charette
Journal:  Chem Rev       Date:  2003-04       Impact factor: 60.622

Review 2.  Biocatalysis--key to sustainable industrial chemistry.

Authors:  Roland Wohlgemuth
Journal:  Curr Opin Biotechnol       Date:  2010-10-26       Impact factor: 9.740

3.  Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.

Authors:  Chen Chen; Brian Dyck; Beth A Fleck; Alan C Foster; Jonathan Grey; Florence Jovic; Michael Mesleh; Kasey Phan; Junko Tamiya; Troy Vickers; Mingzhu Zhang
Journal:  Bioorg Med Chem Lett       Date:  2008-01-09       Impact factor: 2.823

Review 4.  Expanding P450 catalytic reaction space through evolution and engineering.

Authors:  John A McIntosh; Christopher C Farwell; Frances H Arnold
Journal:  Curr Opin Chem Biol       Date:  2014-03-20       Impact factor: 8.822

5.  Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.

Authors:  Junko Tamiya; Brian Dyck; Mingzhu Zhang; Kasey Phan; Beth A Fleck; Anna Aparicio; Florence Jovic; Joe A Tran; Troy Vickers; Jonathan Grey; Alan C Foster; Chen Chen
Journal:  Bioorg Med Chem Lett       Date:  2008-04-15       Impact factor: 2.823

6.  Rhodium-catalyzed enantioselective cyclopropanation of electron deficient alkenes.

Authors:  Hengbin Wang; David M Guptill; Adrian Varela Alvarez; Djamaladdin G Musaev; Huw M L Davies
Journal:  Chem Sci       Date:  2013-07       Impact factor: 9.825

7.  Olefin cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes.

Authors:  Pedro S Coelho; Eric M Brustad; Arvind Kannan; Frances H Arnold
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

8.  Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study.

Authors:  Gregory M Asnis; Anjana Bose; Carl P Gommoll; Changzheng Chen; William M Greenberg
Journal:  J Clin Psychiatry       Date:  2013-03       Impact factor: 4.384

9.  (+/-)-(Z)-2-(aminomethyl)-1-phenylcyclopropanecarboxamide derivatives as a new prototype of NMDA receptor antagonists.

Authors:  S Shuto; H Takada; D Mochizuki; R Tsujita; Y Hase; S Ono; N Shibuya; A Matsuda
Journal:  J Med Chem       Date:  1995-07-21       Impact factor: 7.446

10.  A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo.

Authors:  Pedro S Coelho; Z Jane Wang; Maraia E Ener; Stefanie A Baril; Arvind Kannan; Frances H Arnold; Eric M Brustad
Journal:  Nat Chem Biol       Date:  2013-06-23       Impact factor: 15.040

  10 in total
  15 in total

Review 1.  Expanding the enzyme universe: accessing non-natural reactions by mechanism-guided directed evolution.

Authors:  Hans Renata; Z Jane Wang; Frances H Arnold
Journal:  Angew Chem Int Ed Engl       Date:  2015-02-03       Impact factor: 15.336

2.  Stereoselective Cyclopropanation of Electron-Deficient Olefins with a Cofactor Redesigned Carbene Transferase Featuring Radical Reactivity.

Authors:  Daniela M Carminati; Rudi Fasan
Journal:  ACS Catal       Date:  2019-09-05       Impact factor: 13.084

3.  Nature's Machinery, Repurposed: Expanding the Repertoire of Iron-Dependent Oxygenases.

Authors:  Noah P Dunham; Frances H Arnold
Journal:  ACS Catal       Date:  2020-09-28       Impact factor: 13.084

4.  Stereoselective olefin cyclopropanation under aerobic conditions with an artificial enzyme incorporating an iron-chlorin e6 cofactor.

Authors:  Gopeekrishnan Sreenilayam; Eric J Moore; Viktoria Steck; Rudi Fasan
Journal:  ACS Catal       Date:  2017-10-09       Impact factor: 13.084

5.  Gram-Scale Synthesis of Chiral Cyclopropane-Containing Drugs and Drug Precursors with Engineered Myoglobin Catalysts Featuring Complementary Stereoselectivity.

Authors:  Priyanka Bajaj; Gopeekrishnan Sreenilayam; Vikas Tyagi; Rudi Fasan
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-25       Impact factor: 15.336

6.  Interfacing microbial styrene production with a biocompatible cyclopropanation reaction.

Authors:  Stephen Wallace; Emily P Balskus
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-29       Impact factor: 15.336

7.  Highly Diastereo- and Enantioselective Synthesis of Trifluoromethyl-Substituted Cyclopropanes via Myoglobin-Catalyzed Transfer of Trifluoromethylcarbene.

Authors:  Antonio Tinoco; Viktoria Steck; Vikas Tyagi; Rudi Fasan
Journal:  J Am Chem Soc       Date:  2017-04-10       Impact factor: 15.419

8.  A Continuing Career in Biocatalysis: Frances H. Arnold.

Authors:  Rudi Fasan; S B Jennifer Kan; Huimin Zhao
Journal:  ACS Catal       Date:  2019-09-17       Impact factor: 13.084

9.  Metal Substitution Modulates the Reactivity and Extends the Reaction Scope of Myoglobin Carbene Transfer Catalysts.

Authors:  Gopeekrishnan Sreenilayam; Eric J Moore; Viktoria Steck; Rudi Fasan
Journal:  Adv Synth Catal       Date:  2017-04-12       Impact factor: 5.837

10.  Organic solvent stability and long-term storage of myoglobin-based carbene transfer biocatalysts.

Authors:  Alfons J Pineda-Knauseder; David A Vargas; Rudi Fasan
Journal:  Biotechnol Appl Biochem       Date:  2020-07-09       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.